Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization.
Identifieur interne : 001752 ( Ncbi/Merge ); précédent : 001751; suivant : 001753Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization.
Auteurs : N. Lee [Hong Kong] ; T H Rainer ; M. Ip ; B. Zee ; M H Ng ; G E Antonio ; E. Chan ; G. Lui ; C S Cockram ; J J Sung ; D S HuiSource :
- European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [ 0934-9723 ] ; 2006.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Bilirubine (sang), Diagnostic différentiel, Facteurs de risque, Femelle, Granulocytes neutrophiles (cytologie), Guides de bonnes pratiques cliniques comme sujet, Humains, Infections communautaires (diagnostic), Infections communautaires (microbiologie), Mâle, Numération des leucocytes, Pneumopathie virale (diagnostic), Pneumopathie virale (sang), Sujet âgé, Sujet âgé de 80 ans ou plus, Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (sang), Virus du SRAS (pathogénicité), Études rétrospectives.
- MESH :
- cytologie : Granulocytes neutrophiles.
- diagnostic : Infections communautaires, Pneumopathie virale, Syndrome respiratoire aigu sévère.
- microbiologie : Infections communautaires.
- pathogénicité : Virus du SRAS.
- sang : Bilirubine, Pneumopathie virale, Syndrome respiratoire aigu sévère.
- Adulte d'âge moyen, Diagnostic différentiel, Facteurs de risque, Femelle, Guides de bonnes pratiques cliniques comme sujet, Humains, Mâle, Numération des leucocytes, Sujet âgé, Sujet âgé de 80 ans ou plus, Études rétrospectives.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Bilirubin (blood), Community-Acquired Infections (diagnosis), Community-Acquired Infections (microbiology), Diagnosis, Differential, Female, Humans, Leukocyte Count, Male, Middle Aged, Neutrophils (cytology), Pneumonia, Viral (blood), Pneumonia, Viral (diagnosis), Practice Guidelines as Topic, Retrospective Studies, Risk Factors, SARS Virus (pathogenicity), Severe Acute Respiratory Syndrome (blood), Severe Acute Respiratory Syndrome (diagnosis).
- MESH :
- chemical , blood : Bilirubin.
- blood : Pneumonia, Viral, Severe Acute Respiratory Syndrome.
- cytology : Neutrophils.
- diagnosis : Community-Acquired Infections, Pneumonia, Viral, Severe Acute Respiratory Syndrome.
- microbiology : Community-Acquired Infections.
- pathogenicity : SARS Virus.
- Aged, Aged, 80 and over, Diagnosis, Differential, Female, Humans, Leukocyte Count, Male, Middle Aged, Practice Guidelines as Topic, Retrospective Studies, Risk Factors.
Abstract
The Centers for Disease Control and Prevention (CDC) recommend that SARS-coronavirus (SARS-CoV) testing be considered in epidemiologically high-risk patients hospitalized with community-acquired pneumonia (CAP) if no alternative diagnosis is identified after 72 h. The aim of this study was to identify routine laboratory variables that might indicate the need for SARS-CoV testing. Routine hematological/biochemical variables in patients with laboratory-confirmed SARS (2003) were compared with those in consecutive patients hospitalized June-December 2004 with radiologically confirmed CAP. Stepwise logistic regression analyses were performed to identify discriminating variables at baseline and by day 3 of hospitalization. Nasopharyngeal aspiration and antigen detection for influenza virus and respiratory syncytial virus using an immunofluorescence assay (IFA) were routinely performed in patients with CAP. Altogether, 181 patients with CAP (who remained undiagnosed by IFA) and 303 patients with SARS were studied. The mean intervals from symptom onset to admission were 3.1 and 2.8 days, respectively (p > 0.05). The etiological agent of CAP was identified retrospectively in only 39% of cases, the majority being bacterial pathogens. At baseline, age and absolute neutrophil count (ANC) were the only independent discriminating variables (p < 0.0001). Using a value of <4.4 x 10(9)/l as the cutoff for ANC, the sensitivity and specificity of ANC for discriminating SARS were 64 and 95%, respectively (AUC 0.90). By day 3 of hospitalization, age (p < 0.0001), change in ANC (p = 0.0003), and change in bilirubin (p = 0.0065) were discriminating variables. A model combining age <65 years, a change in ANC of >-3 x 10(9)/l, and a change in bilirubin of > or =0 mmol/l had a sensitivity of 43% and a specificity of 95% for SARS (AUC 0.90). There are only a few laboratory features (including lymphopenia) that clearly discriminate SARS from other causes of CAP. Nevertheless, when evaluating epidemiologically high-risk patients with CAP and no immediate alternative diagnosis, a low ANC on presentation along with poor clinical and laboratory responses after 72 h of antibiotic treatment may raise the index of suspicion for SARS and indicate a need to perform SARS-CoV testing.
DOI: 10.1007/s10096-006-0222-z
PubMed: 17077967
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002001
- to stream PubMed, to step Curation: 002001
- to stream PubMed, to step Checkpoint: 002031
Links to Exploration step
pubmed:17077967Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization.</title>
<author><name sortKey="Lee, N" sort="Lee, N" uniqKey="Lee N" first="N" last="Lee">N. Lee</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.</nlm:affiliation>
<country xml:lang="fr">Hong Kong</country>
<wicri:regionArea>Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories</wicri:regionArea>
<orgName type="university">Université chinoise de Hong Kong</orgName>
<placeName><settlement type="city">Sha Tin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rainer, T H" sort="Rainer, T H" uniqKey="Rainer T" first="T H" last="Rainer">T H Rainer</name>
</author>
<author><name sortKey="Ip, M" sort="Ip, M" uniqKey="Ip M" first="M" last="Ip">M. Ip</name>
</author>
<author><name sortKey="Zee, B" sort="Zee, B" uniqKey="Zee B" first="B" last="Zee">B. Zee</name>
</author>
<author><name sortKey="Ng, M H" sort="Ng, M H" uniqKey="Ng M" first="M H" last="Ng">M H Ng</name>
</author>
<author><name sortKey="Antonio, G E" sort="Antonio, G E" uniqKey="Antonio G" first="G E" last="Antonio">G E Antonio</name>
</author>
<author><name sortKey="Chan, E" sort="Chan, E" uniqKey="Chan E" first="E" last="Chan">E. Chan</name>
</author>
<author><name sortKey="Lui, G" sort="Lui, G" uniqKey="Lui G" first="G" last="Lui">G. Lui</name>
</author>
<author><name sortKey="Cockram, C S" sort="Cockram, C S" uniqKey="Cockram C" first="C S" last="Cockram">C S Cockram</name>
</author>
<author><name sortKey="Sung, J J" sort="Sung, J J" uniqKey="Sung J" first="J J" last="Sung">J J Sung</name>
</author>
<author><name sortKey="Hui, D S" sort="Hui, D S" uniqKey="Hui D" first="D S" last="Hui">D S Hui</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:17077967</idno>
<idno type="pmid">17077967</idno>
<idno type="doi">10.1007/s10096-006-0222-z</idno>
<idno type="wicri:Area/PubMed/Corpus">002001</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002001</idno>
<idno type="wicri:Area/PubMed/Curation">002001</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002001</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002031</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002031</idno>
<idno type="wicri:Area/Ncbi/Merge">001752</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization.</title>
<author><name sortKey="Lee, N" sort="Lee, N" uniqKey="Lee N" first="N" last="Lee">N. Lee</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.</nlm:affiliation>
<country xml:lang="fr">Hong Kong</country>
<wicri:regionArea>Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories</wicri:regionArea>
<orgName type="university">Université chinoise de Hong Kong</orgName>
<placeName><settlement type="city">Sha Tin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rainer, T H" sort="Rainer, T H" uniqKey="Rainer T" first="T H" last="Rainer">T H Rainer</name>
</author>
<author><name sortKey="Ip, M" sort="Ip, M" uniqKey="Ip M" first="M" last="Ip">M. Ip</name>
</author>
<author><name sortKey="Zee, B" sort="Zee, B" uniqKey="Zee B" first="B" last="Zee">B. Zee</name>
</author>
<author><name sortKey="Ng, M H" sort="Ng, M H" uniqKey="Ng M" first="M H" last="Ng">M H Ng</name>
</author>
<author><name sortKey="Antonio, G E" sort="Antonio, G E" uniqKey="Antonio G" first="G E" last="Antonio">G E Antonio</name>
</author>
<author><name sortKey="Chan, E" sort="Chan, E" uniqKey="Chan E" first="E" last="Chan">E. Chan</name>
</author>
<author><name sortKey="Lui, G" sort="Lui, G" uniqKey="Lui G" first="G" last="Lui">G. Lui</name>
</author>
<author><name sortKey="Cockram, C S" sort="Cockram, C S" uniqKey="Cockram C" first="C S" last="Cockram">C S Cockram</name>
</author>
<author><name sortKey="Sung, J J" sort="Sung, J J" uniqKey="Sung J" first="J J" last="Sung">J J Sung</name>
</author>
<author><name sortKey="Hui, D S" sort="Hui, D S" uniqKey="Hui D" first="D S" last="Hui">D S Hui</name>
</author>
</analytic>
<series><title level="j">European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</title>
<idno type="ISSN">0934-9723</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Bilirubin (blood)</term>
<term>Community-Acquired Infections (diagnosis)</term>
<term>Community-Acquired Infections (microbiology)</term>
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Humans</term>
<term>Leukocyte Count</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neutrophils (cytology)</term>
<term>Pneumonia, Viral (blood)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Practice Guidelines as Topic</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>SARS Virus (pathogenicity)</term>
<term>Severe Acute Respiratory Syndrome (blood)</term>
<term>Severe Acute Respiratory Syndrome (diagnosis)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Bilirubine (sang)</term>
<term>Diagnostic différentiel</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Granulocytes neutrophiles (cytologie)</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Infections communautaires (diagnostic)</term>
<term>Infections communautaires (microbiologie)</term>
<term>Mâle</term>
<term>Numération des leucocytes</term>
<term>Pneumopathie virale (diagnostic)</term>
<term>Pneumopathie virale (sang)</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Syndrome respiratoire aigu sévère (diagnostic)</term>
<term>Syndrome respiratoire aigu sévère (sang)</term>
<term>Virus du SRAS (pathogénicité)</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Bilirubin</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Pneumonia, Viral</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr"><term>Granulocytes neutrophiles</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Neutrophils</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Community-Acquired Infections</term>
<term>Pneumonia, Viral</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections communautaires</term>
<term>Pneumopathie virale</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Infections communautaires</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Community-Acquired Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Bilirubine</term>
<term>Pneumopathie virale</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Humans</term>
<term>Leukocyte Count</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Practice Guidelines as Topic</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Diagnostic différentiel</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Guides de bonnes pratiques cliniques comme sujet</term>
<term>Humains</term>
<term>Mâle</term>
<term>Numération des leucocytes</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Centers for Disease Control and Prevention (CDC) recommend that SARS-coronavirus (SARS-CoV) testing be considered in epidemiologically high-risk patients hospitalized with community-acquired pneumonia (CAP) if no alternative diagnosis is identified after 72 h. The aim of this study was to identify routine laboratory variables that might indicate the need for SARS-CoV testing. Routine hematological/biochemical variables in patients with laboratory-confirmed SARS (2003) were compared with those in consecutive patients hospitalized June-December 2004 with radiologically confirmed CAP. Stepwise logistic regression analyses were performed to identify discriminating variables at baseline and by day 3 of hospitalization. Nasopharyngeal aspiration and antigen detection for influenza virus and respiratory syncytial virus using an immunofluorescence assay (IFA) were routinely performed in patients with CAP. Altogether, 181 patients with CAP (who remained undiagnosed by IFA) and 303 patients with SARS were studied. The mean intervals from symptom onset to admission were 3.1 and 2.8 days, respectively (p > 0.05). The etiological agent of CAP was identified retrospectively in only 39% of cases, the majority being bacterial pathogens. At baseline, age and absolute neutrophil count (ANC) were the only independent discriminating variables (p < 0.0001). Using a value of <4.4 x 10(9)/l as the cutoff for ANC, the sensitivity and specificity of ANC for discriminating SARS were 64 and 95%, respectively (AUC 0.90). By day 3 of hospitalization, age (p < 0.0001), change in ANC (p = 0.0003), and change in bilirubin (p = 0.0065) were discriminating variables. A model combining age <65 years, a change in ANC of >-3 x 10(9)/l, and a change in bilirubin of > or =0 mmol/l had a sensitivity of 43% and a specificity of 95% for SARS (AUC 0.90). There are only a few laboratory features (including lymphopenia) that clearly discriminate SARS from other causes of CAP. Nevertheless, when evaluating epidemiologically high-risk patients with CAP and no immediate alternative diagnosis, a low ANC on presentation along with poor clinical and laboratory responses after 72 h of antibiotic treatment may raise the index of suspicion for SARS and indicate a need to perform SARS-CoV testing.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17077967</PMID>
<DateCompleted><Year>2007</Year>
<Month>02</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0934-9723</ISSN>
<JournalIssue CitedMedium="Print"><Volume>25</Volume>
<Issue>12</Issue>
<PubDate><Year>2006</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</Title>
<ISOAbbreviation>Eur. J. Clin. Microbiol. Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization.</ArticleTitle>
<Pagination><MedlinePgn>765-72</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The Centers for Disease Control and Prevention (CDC) recommend that SARS-coronavirus (SARS-CoV) testing be considered in epidemiologically high-risk patients hospitalized with community-acquired pneumonia (CAP) if no alternative diagnosis is identified after 72 h. The aim of this study was to identify routine laboratory variables that might indicate the need for SARS-CoV testing. Routine hematological/biochemical variables in patients with laboratory-confirmed SARS (2003) were compared with those in consecutive patients hospitalized June-December 2004 with radiologically confirmed CAP. Stepwise logistic regression analyses were performed to identify discriminating variables at baseline and by day 3 of hospitalization. Nasopharyngeal aspiration and antigen detection for influenza virus and respiratory syncytial virus using an immunofluorescence assay (IFA) were routinely performed in patients with CAP. Altogether, 181 patients with CAP (who remained undiagnosed by IFA) and 303 patients with SARS were studied. The mean intervals from symptom onset to admission were 3.1 and 2.8 days, respectively (p > 0.05). The etiological agent of CAP was identified retrospectively in only 39% of cases, the majority being bacterial pathogens. At baseline, age and absolute neutrophil count (ANC) were the only independent discriminating variables (p < 0.0001). Using a value of <4.4 x 10(9)/l as the cutoff for ANC, the sensitivity and specificity of ANC for discriminating SARS were 64 and 95%, respectively (AUC 0.90). By day 3 of hospitalization, age (p < 0.0001), change in ANC (p = 0.0003), and change in bilirubin (p = 0.0065) were discriminating variables. A model combining age <65 years, a change in ANC of >-3 x 10(9)/l, and a change in bilirubin of > or =0 mmol/l had a sensitivity of 43% and a specificity of 95% for SARS (AUC 0.90). There are only a few laboratory features (including lymphopenia) that clearly discriminate SARS from other causes of CAP. Nevertheless, when evaluating epidemiologically high-risk patients with CAP and no immediate alternative diagnosis, a low ANC on presentation along with poor clinical and laboratory responses after 72 h of antibiotic treatment may raise the index of suspicion for SARS and indicate a need to perform SARS-CoV testing.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rainer</LastName>
<ForeName>T H</ForeName>
<Initials>TH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ip</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zee</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ng</LastName>
<ForeName>M H</ForeName>
<Initials>MH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Antonio</LastName>
<ForeName>G E</ForeName>
<Initials>GE</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chan</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lui</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cockram</LastName>
<ForeName>C S</ForeName>
<Initials>CS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sung</LastName>
<ForeName>J J</ForeName>
<Initials>JJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hui</LastName>
<ForeName>D S</ForeName>
<Initials>DS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA>
<NlmUniqueID>8804297</NlmUniqueID>
<ISSNLinking>0934-9723</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>RFM9X3LJ49</RegistryNumber>
<NameOfSubstance UI="D001663">Bilirubin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001663" MajorTopicYN="N">Bilirubin</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007958" MajorTopicYN="N">Leukocyte Count</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year>
<Month>11</Month>
<Day>2</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2006</Year>
<Month>11</Month>
<Day>2</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17077967</ArticleId>
<ArticleId IdType="doi">10.1007/s10096-006-0222-z</ArticleId>
<ArticleId IdType="pmc">PMC7088362</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Eur J Clin Microbiol Infect Dis. 2006 Apr;25(4):230-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16586072</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2004 Dec 15;39(12):1818-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15578405</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2000 Aug;31(2):347-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10987697</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Respir J. 2005 Sep;26(3):474-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16135731</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 Jun;10(6):1168-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15224676</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 1996 Jun;22(6):1096-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8783719</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2003 Jun 21;326(7403):1354-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12816820</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Kidney Dis. 2003 Nov;42(5):1069-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14582051</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2005 Mar 1;171(5):461-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15531752</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Respir Med. 2005 Sep;99(9):1079-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16085210</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2003 Jun 21;326(7403):1358-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12816821</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2004 Sep 7;141(5):333-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15326019</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2003 Dec 1;37(11):1405-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14614663</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>World J Gastroenterol. 2005 Apr 14;11(14):2148-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15810082</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2005 Feb;11(2):191-200</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15752435</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2005 Apr 15;40(8):1079-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15791504</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Dis Child. 2005 Jul;90(7):747-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15970619</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 2003 Jan 21;138(2):109-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12529093</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12682352</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2004 May;59(5):414-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15115870</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2006 Feb;35(2):179-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16112612</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2004 Feb 15;189(4):648-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14767818</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 Jun;10(6):1143-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15207072</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Hong Kong</li>
</country>
<settlement><li>Sha Tin</li>
</settlement>
<orgName><li>Université chinoise de Hong Kong</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Antonio, G E" sort="Antonio, G E" uniqKey="Antonio G" first="G E" last="Antonio">G E Antonio</name>
<name sortKey="Chan, E" sort="Chan, E" uniqKey="Chan E" first="E" last="Chan">E. Chan</name>
<name sortKey="Cockram, C S" sort="Cockram, C S" uniqKey="Cockram C" first="C S" last="Cockram">C S Cockram</name>
<name sortKey="Hui, D S" sort="Hui, D S" uniqKey="Hui D" first="D S" last="Hui">D S Hui</name>
<name sortKey="Ip, M" sort="Ip, M" uniqKey="Ip M" first="M" last="Ip">M. Ip</name>
<name sortKey="Lui, G" sort="Lui, G" uniqKey="Lui G" first="G" last="Lui">G. Lui</name>
<name sortKey="Ng, M H" sort="Ng, M H" uniqKey="Ng M" first="M H" last="Ng">M H Ng</name>
<name sortKey="Rainer, T H" sort="Rainer, T H" uniqKey="Rainer T" first="T H" last="Rainer">T H Rainer</name>
<name sortKey="Sung, J J" sort="Sung, J J" uniqKey="Sung J" first="J J" last="Sung">J J Sung</name>
<name sortKey="Zee, B" sort="Zee, B" uniqKey="Zee B" first="B" last="Zee">B. Zee</name>
</noCountry>
<country name="Hong Kong"><noRegion><name sortKey="Lee, N" sort="Lee, N" uniqKey="Lee N" first="N" last="Lee">N. Lee</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001752 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001752 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:17077967 |texte= Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:17077967" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |